Transplant rejection study

The research will be conducted in the RITT Industrial BioDevelopment Laboratory at the Toronto General Hospital. As part of this collaboration, the state-of-the-art RITT Industrial BioDevelopment Laboratory (IBDL) has been equipped with over $1,000,000 (Canadian) of Thermo laboratory equipment, making this one of the IBDL’s biggest investments in a single supplier.

The RITT programme is a new $10 million initiative that aims to fully understand the biology of transplant rejection in order to develop treatments to prevent it. The program is part of the research armof the Multi Organ Transplant Program – one of North America’s largest transplant programmes.

As well as equipping the IBDL with biological safety cabinets, incubators, freezers, microplate instrumentation, a KingFisher magnetic particle processor, and a liquid chromatography and mass spectrometry system (LC/MS), Thermo will also support the RITT program’s objectives by funding a post-doctoral research scientist for two years. The ‘Thermo Electron Corporation Bioanalytical Post-doctoral Fellow’ will work on projects of joint interest to the RITT programme and Thermo in the areas of assay development and biomolecule purification using the latest Thermo instrumentation. Additionally, Thermo will provide training workshops in its many areas of expertise.